| Systematic (IUPAC) name | |
|---|---|
| (1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-(β-D-ribofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 53797-35-6 |
| ATC code | J01GB10 |
| PubChem | CID 5066 |
| UNII | 2Q5JOU7T53 |
| ChEMBL | CHEMBL1256830 |
| Synonyms | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol |
| Chemical data | |
| Formula | C17H34N4O10 |
| Mol. mass | 454.47266 g/mol |
| (what is this?) (verify) |
|
Ribostamycin (INN) is an aminoglycoside antibiotic.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||